Skip to content
LookupMeds

Active ingredient

Rivastigmine

72 finished FDA listings contain Rivastigmine as their only active ingredient.

See all listingsCompare with another medication

FDA NDC Directory

Ingredient names as written by FDA
RIVASTIGMINE, RIVASTIGMINE TARTRATE
Dosage forms
Capsule, Patch, Patch, Extended Release
Routes
Oral, Transdermal
Manufacturers / labelers
20
Strengths listed
1.5 mg/1 · 13.3 mg/24h · 3 mg/1 · 4.5 mg/1 · 4.6 mg/24h · 6 mg/1 · 9.5 mg/24h
Brand names in FDA listings
Exelon, Rivastigmine Transdermal System

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 183379

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 022083SANDOZ2007-07-069
ANDA 077131SUN PHARM2007-10-224
ANDA 077130DR REDDYS LABS INC2007-10-315
ANDA 091689ALEMBIC PHARMS LTD2012-06-128
ANDA 203148MACLEODS PHARMS LTD2014-08-224
ANDA 204572AUROBINDO PHARMA2016-03-255
ANDA 203844CADILA PHARMS LTD2017-02-138
ANDA 207797CHARTWELL RX2017-09-284
ANDA 205622MYLAN TECHNOLOGIES2018-06-203
ANDA 207308AMNEAL PHARMS2019-01-083
ANDA 206318ZYDUS PHARMS2019-03-048
ANDA 209063BRECKENRIDGE2019-11-2611

Official labeling on DailyMed

Showing the 12 most recent of 28 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.